A Phase Ⅲ Randomized Clinical Trial of Postmastectomy Hypofractionation Radiotherapy in High-risk Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00793962
Recruitment Status : Active, not recruiting
First Posted : November 19, 2008
Last Update Posted : July 24, 2017
Information provided by (Responsible Party):
Shu lian Wang, Chinese Academy of Medical Sciences

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : May 2016
  Estimated Study Completion Date : May 2021